All filters
Videos
MRI; what can it deliver | Claude Sirlin, MD
Presented at:
International Workshop on NASH Biomarkers 2017
Videos
Circulating nucleic acids and combination panels | Sven Francque, MD, PhD
Presented at:
International Workshop on NASH Biomarkers 2017
Videos
Role of genetic assessments | Quentin Anstee, BSc, MB BS, PhD, MRCP(UK), FRCP
Presented at:
International Workshop on NASH Biomarkers 2017
Videos
Collaboration in action - Innovative Medicines Initiative | Quentin Anstee, BSc, MB BS, PhD, MRCP(UK), FRCP
Presented at:
International Workshop on NASH Biomarkers 2017
Videos
Collaboration in action - Foundation for the National Institutes of Health | Roberto Calle, MD, FACE, FACP
Presented at:
International Workshop on NASH Biomarkers 2017
Videos
Innovation in histological assessment of NASH | Pierre Bedossa, MD, PhD
Presented at:
International Workshop on NASH Biomarkers 2017
Videos
Opening lecture: A pathologist, a radiologist and a hepatologist walked into a bar | Brent Neuschwander-Tetri, MD
Presented at:
International Workshop on NASH Biomarkers 2017
Videos
Gilead: RSV | Erik Mogalian
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Videos
Janssen: Influenza | Thomas Kakuda, PharmD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Videos
Merck: CMV | Cyrus Badshah, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Videos
Con Standpoint | Jürgen Rockstroh, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Videos
Pro Standpoint | Nancy Reau, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Videos
Long Acting Antivirals: Advanced drug delivery | Mark Milad, PharmD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Videos
DDI’s in Aging HCV infected Patients | Elise Smolders, MSc
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Videos
FDA perspective | Kellie Reynolds, PharmD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Videos
HBV therapy & Approaches to Cure | Jordan Feld, MD, MPH
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Videos
Clinical Aspects of Pediatric Treatment | Tim Cressey, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Videos
Current Challenges in Pediatric Drug Development | Robert Ward, MD, FAAP, FCP
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Videos
Current and Future Treatment of CMV | Robin Avery, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Videos
Management of DAA Failures | Gregory T. Everson, MD
Presented at:
Optimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016
Videos
Post-LT Renal Failure and HCV Rx | Peter Ferenci, MD
Presented at:
Optimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016
Videos
Obstacles to Treatment: Renal Disease, Ribavirin, DDIs | Michael Charlton, MD
Presented at:
Optimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016
Videos
What Are the Treatment Options? | Maria Londoño, MD
Presented at:
Optimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016
Videos
Use of HCV+ Donor Grafts | Didier Samuel, MD, PhD
Presented at:
Optimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016